// App-Quantinova.ai

238 2015 ATVB : Distinct Vascular Effects of Celecoxib and Rofecoxib in vivo

Researchers

Presenter

  • Tilo Grosser

Principal Investigators

  • Gregory R Grant

  • Shu-Lin Liu

  • John A Lawson

  • Richard Assoian

  • Garret A FitzGerald

Medical Centers

  • University of Pennsylvania, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Cyclooxygenase-1

Drug/Treatment

  • Prostacyclin

  • Celecoxib

  • ALT-210

  • Rofecoxib

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved